Press release
Strong Growth Ahead: Peptide Based Metabolic Disorders Therapeutics Market Size To Grow At Arecord 14.8% Cagr By 2029
Peptide Based Metabolic Disorders Therapeutics
How Big Is the Peptide Based Metabolic Disorders Therapeutics Market Size Expected to Be by 2034?
The peptide-based metabolic disorders therapeutics market has grown rapidly in recent years. It will rise from $29.89 billion in 2024 to $34.4 billion in 2025, with a CAGR of 15.1%. The historic growth has been driven by the rising prevalence of metabolic disorders, advancements in peptide synthesis technologies, increasing TH*Care expenditure, an aging population, an expanding biopharmaceutical sector, regulatory approvals for new treatments, and growing awareness of personalized medicine.
The peptide-based metabolic disorders therapeutics market is anticipated to grow rapidly, reaching $59.85 billion by 2029 at a CAGR of 14.8%. Growth drivers include the development of novel peptide analogs, rising investments in R&D for metabolic disorders, the adoption of precision medicine, expanding markets in emerging economies, collaborations in drug development, advancements in delivery technologies, and a focus on patient-centric therapies. Key trends include the application of artificial intelligence in drug discovery, the growth of personalized therapies, the use of CRISPR/Cas9 for genetic therapies, the integration of wearable devices for patient monitoring, the development of oral peptide formulations, digital therapeutics, and the expansion of biobanking for personalized treatments.
Purchase the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=16764
What Are the Emerging Segments Within the Peptide Based Metabolic Disorders Therapeutics Market?
The peptide based metabolic disorders therapeutics market covered in this report is segmented -
1) By Drug Type: Liraglutide, Exenatide, Other Drug Type
2) By Application: Lysosomal Storage Diseases, Diabetes, Obesity, Hypercholesterolemia, Other Applications
3) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies
Subsegments:
1) By Liraglutide: Brand: Saxenda, Brand: Victoza, Generic Liraglutide, Liraglutide For Type 2 Diabetes, Liraglutide For Obesity
2) By Exenatide: Brand: Byetta, Brand: Bydureon, Exenatide For Type 2 Diabetes, Extended-Release Exenatide, Generic Exenatide
3) By Other Drug Type: Semaglutide, Dulaglutide, Albiglutide, Lixisenatide, GLP-1 Receptor Agonists, Pramlintide, Other Peptide-Based Drugs For Metabolic Disorders
Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=16764&type=smp
What Long-Term Drivers Are Shaping Peptide Based Metabolic Disorders Therapeutics Market Trends?
The rising prevalence of obesity is expected to fuel the growth of the peptide-based metabolic disorders therapeutic market. Obesity, resulting from sedentary lifestyles, poor diets, and genetic factors, is a leading cause of metabolic disorders, and peptide-based treatments help manage conditions such as obesity by improving insulin sensitivity and regulating metabolism. For instance, in April 2024, the British Diabetic Association reported that 4.4 million people in the UK have diabetes, contributing to a demand for obesity-related therapeutics. Therefore, the growing prevalence of obesity is driving the growth of the peptide-based metabolic disorders therapeutic market.
Who Are the Top Competitors in Key Peptide Based Metabolic Disorders Therapeutics Market Segments?
Major companies operating in the peptide based metabolic disorders therapeutics market are Pfizer Inc., Johnson And Johnson, Roche Holding AG, Merck And Co. Inc., AbbVie Inc., Sanofi SA, Bristol-Myers Squibb Company, AstraZeneca PLC, Novartis AG, Takeda Pharmaceutical Company Limited, GlaxoSmithKline plc, Boehringer Ingelheim International GmbH, Eli Lilly Company, Amgen Inc., Gilead Sciences Inc., Novo Nordisk A/S, Teva Pharmaceutical Industries Ltd., Regeneron Pharmaceuticals Inc., Biogen Inc., Vertex Pharmaceuticals Incorporated, Jazz Pharmaceuticals plc, Ipsen S.A, BioMarin Pharmaceutical Inc., Amarin Corporation plc, PolyPeptide Group
What Are the Latest Developing Trends in the Peptide Based Metabolic Disorders Therapeutics Market?
Companies in the peptide-based metabolic disorders therapeutics market are creating biosimilar drugs for conditions like diabetes to offer affordable, effective treatment alternatives. These biosimilars replicate existing peptide therapies while reducing costs. In January 2024, Glenmark Pharmaceuticals Ltd., an India-based pharmaceutical firm, introduced Lirafit, a biosimilar of Liraglutide in India. As a GLP-1 receptor agonist, Lirafit regulates blood sugar, supports weight loss, and enhances cardiovascular health. Clinical trials have confirmed its efficacy and safety.
Get the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/report/peptide-based-metabolic-disorders-therapeutics-global-market-report
Which Regions Are Becoming Hubs for Peptide Based Metabolic Disorders Therapeutics Market Innovation?
North America was the largest region in the peptide based metabolic disorders therapeutics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the peptide based metabolic disorders therapeutics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Frequently Asked Questions:
1. What Is the Market Size and Growth Rate of the Peptide Based Metabolic Disorders Therapeutics Market?
2. What is the CAGR expected in the Peptide Based Metabolic Disorders Therapeutics Market?
3. What Are the Key Innovations Transforming the Peptide Based Metabolic Disorders Therapeutics Industry?
4. Which Region Is Leading the Peptide Based Metabolic Disorders Therapeutics Market?
Why This Report Matters:
Competitive overview: This report analyzes the competitive landscape of the 3D imaging software market, evaluating key players on market share, revenue, and growth factors.
Informed Decisions: Understand key strategies related to products, segmentation, and industry trends.
Efficient Research: Quickly identify market growth, leading players, and major segments.
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Strong Growth Ahead: Peptide Based Metabolic Disorders Therapeutics Market Size To Grow At Arecord 14.8% Cagr By 2029 here
News-ID: 4041477 • Views: …
More Releases from The Business Research Company
Emerging Markets And Increasing Disposable Income Fueling Diamond Market Growth: …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Diamond Market Through 2025?
In the past few years, there has been a stable expansion in the diamond market size. The prediction is it will increase from $1.33 billion in 2024 to $1.39 billion in 2025, boasting a compound annual growth rate…
2025-2034 Nonmetallic Minerals Mining Support Activities Market Outlook: Key Dri …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Will the Nonmetallic Minerals Mining Support Activities Industry Market Size Be by 2025?
In the past few years, there has been a robust expansion in the size of the nonmetallic minerals mining support activities market. It is projected to escalate from $34.04 billion in 2024 to $36.55 billion…
Professional Street Sweeper Industry Outlook 2025-2029: Market Set to Cross $3.1 …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
How Large Will the Professional Street Sweeper Market Size By 2025?
The market size of professional street sweepers has seen significant expansion in the past few years. The market, predicted to rise from $2.37 billion in 2024 to $2.5 billion in 2025, boasts a compound annual growth rate (CAGR)…
Key Trends Reshaping the Industrial Wet Dust Collector Market: Advanced Filtrati …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
Industrial Wet Dust Collector Market Size Growth Forecast: What to Expect by 2025?
In recent times, there has been a robust growth in the size of the industrial wet dust collector market. It is expected to swell from $1.89 billion in 2024 to $2 billion by 2025, showing a…
More Releases for Peptide
Copper Peptide GHK-Cu Market: Empowering Beauty and Health Innovations with Adva …
The global copper peptide GHK-Cu market is poised for transformative growth as innovative cosmetic and pharmaceutical formulations increasingly incorporate these bioactive peptides to promote skin rejuvenation, wound healing, and overall wellness. Driven by technological advancements, growing consumer awareness of anti-aging solutions, and an expanding portfolio of product applications, the market is set to evolve rapidly in the coming years. This industry provides an in-depth analysis of market information, key growth…
Shaping the Cell Penetrating Peptide Market in 2025: Innovative Peptide Drug Dis …
How Big Is the Cell Penetrating Peptide Market Expected to Be, and What Will Its Growth Rate Be?
In recent times, the market size for cell penetrating peptides has expanded swiftly. The market is projected to rise from a value of $1.87 billion in 2024 to $2.16 billion in 2025, growing at a compound annual growth rate (CAGR) of 15.6%. The historic period's growth can be credited to an amplified comprehension…
Cancer Peptide Drugs Market
Global Peptide Cancer Drug Market Size, Dosage, Drug Price, Sales & Clinical Trials Insight 2030 Report Highlights:
• Global Peptide Cancer Drug Market Insight By Region & Indication
• Global Peptide Cancer Drug Market Opportunity: > US$ 18 Billion
• Approved Peptide Cancer Drugs: > 30 Drugs
• Approved Peptide Cancer Drugs Sales Insights, Patent, Dosage and Price Analysis
• Peptide Cancer Drugs Clinical Trials Insight By Company, Country, Indication and Phase
• Insight On Peptide Cancer Drugs In Clinical Trials: >…
Growing Adoption of Synthetic Peptide Drugs Driving Peptide Therapeutics Market …
Peptide Therapeutics Market size was valued at USD 40.69 billion in 2019 and is poised to grow from USD 43.11 billion in 2023 to USD 68.4 billion by 2031, growing at a CAGR of 5.94% in the forecast period (2024-2031).
[https://www.skyquestt.com/report/peptide-therapeutics-market] size was valued at USD 43.11 billion in 2023 to USD 68.4 billion by 2031, growing at a CAGR of 5.94% in the forecast period (2024-2031). The increasing prevalence of…
Global Adjuvant Peptide Market Size,Share, Research and Forecast,2023-2028| Pept …
The global Adjuvant Peptide market is carefully researched in the report while largely concentrating on top players and their business tactics, geographical expansion, market segments, competitive landscape, manufacturing, and pricing and cost structures. Each section of the research study is specially prepared to explore key aspects of the global Adjuvant Peptide market. For instance, the market dynamics section digs deep into the drivers, restraints, trends, and opportunities of the global…
Peptide Modifications For PEGylation
PEGylation is the process of covalently attaching polyethylene glycol (PEG) polymer chains to peptides. By increasing their molecular mass and shielding them from proteolytic enzymes, PEGylation improves the pharmacokinetics of peptides and proteins. PEGylation reduces renal clearance and results in more sustained absorption after subcutaneous administration, as well as restricted distribution. PEGylations have been shown to significantly improve water solubility, biocompatibility, immunogenicity, and other physico-chemical properties. It is an established…
